Individualized faricimab dosing up to every 16 weeks maintains robust anatomic and vision outcomes through 2 years in nAMD
Conferences
-
- Overview
-
- Research
-
- Additional Document Info
-
- View All
-
Overview
status
publication date
has subject area
published in
presented at event
Research
keywords
-
Life Sciences & Biomedicine
-
Ophthalmology
-
Science & Technology
Additional Document Info